Join

Compare · QNGY vs TMO

QNGY vs TMO

Side-by-side comparison of Quanergy Systems Inc. (QNGY) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both QNGY and TMO operate in Industrial Machinery/Components (Industrials), so they compete in similar markets.
  • TMO carries a market cap of $225.41B.
  • TMO has hit the wire 6 times in the past 4 weeks while QNGY has been quiet.
  • TMO has more recent analyst coverage (25 ratings vs 0 for QNGY).
MetricQNGYTMO
Company
Quanergy Systems Inc.
Thermo Fisher Scientific Inc
Price
$0.71-7.36%
$469.57+0.63%
Market cap
-
$225.41B
1M return
-
-4.31%
1Y return
-
+11.45%
Industry
Industrial Machinery/Components
Industrial Machinery/Components
Exchange
NYSE
NYSE
IPO
2020
News (4w)
0
6
Recent ratings
0
25
QNGY

Quanergy Systems Inc.

Quanergy Systems, Inc. develops and markets light detection and ranging (LiDAR) solutions for automotive and IoT applications. The company offers M1 LiDAR sensor for mid-long range industrial measurement applications; M1 Edge 2D LiDAR sensor that enables reliable collision avoidance and smart navigation; M8 LiDAR sensor, which provides 3D perception using multiple eye-safe laser beams and time-of-flight measurement technology; MQ-8 LiDAR sensor for flow management applications; M8-Prime 3D LiDAR sensor that provides industry-leading pinpoint accuracy and captures for industrial and mapping applications; S3 solid state LiDAR sensor; QORTEX DTC, a 3D computer perception software; and QORTEX people counter enables the development of accurate and innovative people counting and queue management applications. Its products are used in various applications, such as mapping, security, smart city and smart spaces, industrial automation, and transportation applications. The company was founded in 2012 and is headquartered in Sunnyvale, California.

TMO

Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.